Department of Endocrinology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Department of Endocrinology, Zhejiang Provincial People's Hospital, Hangzhou, China.
Endocr Pract. 2021 Sep;27(9):903-911. doi: 10.1016/j.eprac.2021.02.006. Epub 2021 Feb 17.
Our objective was to investigate the management of patients with asymptomatic suspicious thyroid nodules ≤1 cm.
We retrospectively reviewed medical records of patients with sonographically suspicious thyroid nodules ≤1 cm and without distant metastases, suspicious lymph node metastasis (LNM), or extrathyroidal extension (ETE).
Of the 386 enrolled patients, 174 (45.1%) had immediate surgery (IS), while 212 (54.9%) underwent active surveillance (AS). In the IS group, 166 (95.4%) patients were confirmed as having papillary thyroid microcarcinoma. LNM and ETE were observed in 24.7% and 2.4% cases, respectively. In the AS group, nodule size increased by ≥3 mm in 11 (5.2%) patients and 39 (18.4%) had a >50% increase in nodule volume after a median follow-up of 12 months. Nodules with smaller volume at diagnosis were more likely to increase in volume later. Newly suspicious LNM was detected in 23 (10.8%) patients. Delayed surgery (DS) was performed in 101 patients, with 27 showing disease progression. ETE and LNM were detected in 3% and 36%, respectively, of patients with papillary thyroid microcarcinoma. Compared with IS, tumors in the DS group more frequently showed lateral LNM and capsular invasion (P < .05). No patient had recurrence or died of thyroid cancer during postoperative follow-up (median 26 [4-60] months).
IS or DS of patients with asymptomatic suspicious thyroid nodules ≤1 cm was relatively high in China. The inertia of low-risk nodules and the effectiveness of DS for those that progressed make AS a feasible strategy.
本研究旨在探讨直径≤1cm 无症状可疑甲状腺结节患者的管理方法。
我们回顾性分析了超声检查可疑甲状腺结节直径≤1cm 且无远处转移、可疑淋巴结转移(LNM)或甲状腺外侵犯(ETE)的患者的病历。
在纳入的 386 例患者中,174 例(45.1%)行即刻手术(IS),212 例(54.9%)行主动监测(AS)。在 IS 组中,166 例(95.4%)患者被确诊为甲状腺微小乳头状癌。24.7%和 2.4%的患者分别存在 LNM 和 ETE。在 AS 组中,11 例(5.2%)患者结节增大≥3mm,39 例(18.4%)患者结节体积在中位 12 个月随访时增加>50%。诊断时体积较小的结节更有可能随后增大。23 例(10.8%)患者新出现可疑 LNM。101 例患者行延迟手术(DS),其中 27 例患者疾病进展。在甲状腺微小乳头状癌患者中,分别有 3%和 36%的患者出现 ETE 和 LNM。与 IS 相比,DS 组肿瘤更常出现侧方 LNM 和包膜侵犯(P<.05)。在术后随访期间(中位随访时间 26[4-60]个月),无患者复发或死于甲状腺癌。
在中国,直径≤1cm 无症状可疑甲状腺结节患者行 IS 或 DS 的比例相对较高。低风险结节的惰性和对进展结节行 DS 的有效性使 AS 成为一种可行的策略。